Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000914208-17-000066
Filing Date
2017-02-01
Accepted
2017-02-01 11:51:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 16346
  Complete submission text file 0000914208-17-000066.txt   18387
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39444 | Film No.: 17563788
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309
Business Address 1555 PEACHTREE STREET NE SUITE 1800 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice